The current statistics according to the Centers for Disease Control and Prevention (CDC) state that black individuals have 2.6x more cases, 4.7x more hospitalizations, and 2.7x more deaths than white individuals affected by COVID-19. 
A review of the association between ethnicity, incidence, and outcomes of COVID-19 found minority patients had reduced lung function compared to white individuals. Additionally, there could be an association between COVID-19 and glucose-6-phosphate dehydrogenase (G6PD) deficiency, a deficiency seen more often in African, Asian, and Mediterranean patients. Furthermore, minority ethnicities in poorer socioeconomic circumstances are associated with more comorbidities, potentially leading to more COVID-19 cases. 
A review article assessing clinical characteristics and morbidity associated with COVID-19 in Detroit found that out of 463 patients, 334 (72.1%) were black. Male sex and older age were significantly associated with mortality, whereas African American race was not. 
According to a Centre of Evidence Based Medicine review, a higher mortality risk from COVID-19 is seen among Black, Asian and Minority Ethnic (BAME) groups, but deaths are not consistent across these groups. Similarly, adverse outcomes were seen for BAME patients in intensive care units and amongst medical staff and Health and Care Workers.
The American Public Media (APM) Research Lab states that for each 100,000 Americans, about 88 Blacks have died from the coronavirus, the highest actual mortality rate of all groups—above Asians (36), Whites (40), Latinos (54), Pacific Islanders (64) and Indigenous people (73). If adjusted for age, Blacks are 3.6 times more likely to have died than Whites.